About B3B

This author has not yet filled in any details.
So far B3B has created 228 blog entries.

Event Recap: RESI SF 2017

Networking on Steroids: Early stage entrepreneurs speed date with investors at RESI in San Francisco By Marie Daghlian You have 30 minutes per meeting, enough time to make your pitch, find out if there is a potential connection, and move on to the next meeting. It’s networking on steroids and it works for many of [...]

January 18th, 2017|

September Spotlight:

  The Innovative Genomics Initiative (IGI) is currently soliciting applications for its new Entrepreneurial Fellows Program at UC Berkeley. Designed to catalyze the translation and commercialization of innovative research discoveries for practical benefit, this new program builds strong support networks in which accomplished, entrepreneurial-minded researchers are enabled to make substantial contributions to the biotech economy, [...]

September 23rd, 2016|

September Spotlight:
Charles River Hosting Viral Clearance and Viral Safety Summit in Foster City

Date: October 18 – 19, 2016 Location: Crowne Plaza Hotel, 1221 Chess Drive, Foster City, CA 94404 Agenda/Registration: www.criver.com/summit16 This two-day summit, located in the eclectic Bay Area, unites industry professionals in an interactive setting to share updates and discuss trends in the realm of viral safety and viral clearance.  Also, during the summit, four [...]

August 25th, 2016|

Gilead Takes ‘Low Road’

Full feature More coverage: TheStreet: Gilead Sciences Bucks Tradition, Takes 'Low Road' on New Hepatitis C Drug Price More FierceBiotech: New Gilead hep C combo Epclusa gains FDA approval More STAT: FDA approves a Gilead pill that is first to treat all forms of hepatitis C More

June 29th, 2016|

Event Recap: Medical Devices Take the Spotlight

By Marie Daghlian; Photos by Eugene Borodin A smart contact lens that monitors blood glucose, video games that promise to enhance cognition, a novel and simple biopsy device that improves patient comfort—these are just a few of the next generation of medical devices showcased at the third annual Rosenman Institute Symposium, held June 22nd at Byers [...]

June 29th, 2016|

KaloBios Reinvents Itself and How to Price Drugs

From The Bio Report/Daniel Levine: "KaloBios, a biotech best known for a series of disastrous events including failed clinical trials, a bankruptcy filing, lawsuits, and the arrest of its CEO, is being reborn. In the process, it may provide a valuable contribution to the ongoing discussion over drug pricing. In April, the development-stage company unveiled [...]

June 23rd, 2016|

Event Recap: ISSCR Conference

By Dr. Karen Ring for CIRM/Big3Bio: CIRM kicked off the 2016 International Society for Stem Cell Research (ISSCR) Conference in San Francisco with a public stem cell event yesterday that brought scientists, patients, patient advocates and members of the general public together to discuss the many ways stem cells are being used in the clinic [...]

June 23rd, 2016|

This Bloody Plant Burger Smells, Tastes And Sizzles Like Meat

From NPR: "This summer, diners in New York, San Francisco and Los Angeles will get their hands on a hamburger that has been five years in the making. The burger looks, tastes and smells like beef — except it's made entirely from plants. It sizzles on the grill and even browns and oozes fat when [...]

June 21st, 2016|

Sean Parker to Fund Groundbreaking CRISPR Trial

UPDATE: A federal ethics and biosafety panel has approved the trial - coverage: Nature: First CRISPR clinical trial gets green light from US panel STAT: Federal panel approves first use of CRISPR in humans PREVIOUS: Internet billionaire Sean Parker is funding the first proposed test of CRISPR gene-editing technology in human beings. It would mark the first clinical trial involving CRISPR. Excerpts [...]

June 21st, 2016|

Cerus Wins Up-to-$180.5M BARDA Contract

Excerpt of coverage from GEN: "Under the BARDA contract, Cerus will receive initial funding of up to $30,750,939 to support activities related to a clinical trial to assess the safety and efficacy of Intercept RBCs compared to conventional RBCs in Puerto Rico, which has been impacted by the Zika virus epidemic. This funding also will [...]

June 20th, 2016|